JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB204448

Anti-CRISPR-Cas9 抗体

Anti-CRISPR-Cas9 antibody

3

(1 Review)

|

(25 Publications)

Rabbit Polyclonal CRISPR-Cas9 antibody. Suitable for IP, Flow Cyt, WB, ICC/IF and reacts with Transfected cell lysate - Streptococcus pyogenes, Transfected cell line - Streptococcus pyogenes samples. Cited in 25 publications. Immunogen corresponding to Recombinant Fragment Protein within Streptococcus pyogenes serotype M1 cas9.

別名を表示する

csn1, SPy_1046, cas9, CRISPR-associated endonuclease Cas9/Csn1, SpCas9, SpyCas9

4 Images
Flow Cytometry - Anti-CRISPR-Cas9 antibody (AB204448)
  • Flow Cyt

Supplier Data

Flow Cytometry - Anti-CRISPR-Cas9 antibody (AB204448)

Flow cytometric analysis of HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) cells (upper panel), and transfected with CRISPR-Cas9 (lower panel) labeling CRISPR-Cas9 with ab204448 at 1/5000 dilution.

Cells were fixed with 1% PFA and incubated with the primary antibody (1/5000) at RT for 2 hours.

Immunocytochemistry/ Immunofluorescence - Anti-CRISPR-Cas9 antibody (AB204448)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-CRISPR-Cas9 antibody (AB204448)

Immunofluorescent analysis of U-2 OS (Human bone osteosarcoma epithelial cell line) cells transfected with DDDDK tag-CRISPR-Cas9, labeling CRISPR-Cas9 with ab204448 at 1/10,000 dilution (green). Labeling with anti-DDDDK tag (red). Right hand panel shows merged image with DAPI staining (blue).

Protocol : Fixation with PFA 2% 10 min, permeabilization cold methanol, block with BSA 2% for 1h at RT, incubation with ab204448 1/10,000 1h 30 min at RT.

There is a low background staining with ab204448 which is minimized at 1/10000 dilution.

Immunoprecipitation - Anti-CRISPR-Cas9 antibody (AB204448)
  • IP

Supplier Data

Immunoprecipitation - Anti-CRISPR-Cas9 antibody (AB204448)

Western blot analysis of immunoprecipitate using ab204448 in U-2 OS (Human bone osteosarcoma epithelial cell line) cells extracts.

WB : anti-DDDDK tag.

Lane 1 : Input.
Lane 2 : Immunoprecipitation with control serum (10μl).
Lane 3 : Immunoprecipitation with ab204448 (10μl)

All lanes:

Immunoprecipitation - Anti-CRISPR-Cas9 antibody (ab204448)

false

Western blot - Anti-CRISPR-Cas9 antibody (AB204448)
  • WB

Supplier Data

Western blot - Anti-CRISPR-Cas9 antibody (AB204448)

WB : Transfer in nitrocelullose, block : 1 hour 5% milk in TBST (Tween= 0.2%),

Incubation with primary antibody o/n at 4°C in 5% milk TBST (Tween= 0.2%).

Lanes 1 - 2:

Anti-DDDDK tag antibody

Lanes 3 - 4:

Western blot - Anti-CRISPR-Cas9 antibody (ab204448) at 1/2000 dilution

Lane 1:

HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) cell lysate at 40 µg

Lanes 2 and 4:

HEK-293T cells transfected with DDDDK tag-CRISPR-Cas9 lysate at 40 µg

Lane 3:

HEK-293T cell lysate at 40 µg

Predicted band size: 158 kDa

false

Key facts

宿主種

Rabbit

クローン性

Polyclonal

アイソタイプ

IgG

キャリアフリー

No

交差種

Streptococcus pyogenes

アプリケーション

Flow Cyt, IP, ICC/IF, WB

applications

免疫原

Recombinant Fragment Protein within Streptococcus pyogenes serotype M1 cas9. The exact immunogen used to generate this antibody is proprietary information.

Q99ZW2

特異性

This antibody reacts with CRISPR-Cas9, this antibody has been found to react with 6xHis and Flag tags. If using multiple tags we recommend ab189380.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Streptococcus pyogenes": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "predicted", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Transfected cell line - Streptococcus pyogenes": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Transfected cell lysate - Streptococcus pyogenes": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p>Use 10μl per IP.</p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

製品の詳細

Older lots react with cas9 and the Flag and 6x His tags.

New lots react with only cas9 and the 6x His tag.

Please contact our scientific support team for clarification.

出荷温度及び保存条件

製品の状態
Liquid
精製度
Whole antiserum
バッファー組成
Preservative: 0.05% Sodium azide
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

CRISPR-Cas9 also known simply as Cas9 is a protein that acts as a molecular scissor in gene editing. It has a molecular weight of approximately 160 kDa. Cas9 is a part of the CRISPR-Cas system originally discovered in bacteria where it serves as an adaptive immune system. In bacterial cells Cas9 targets and cleaves specific DNA sequences allowing for targeted gene modifications. While the expression of the CRISPR-Cas system occurs naturally in prokaryotes scientists now harness it in various organisms for genetic manipulation.
Biological function summary

The Cas9 protein functions as an integral part of the CRISPR-Cas9 complex which includes a guide RNA to direct the protein to specific DNA sequences. This complex enables precise cuts at targeted locations within the genome. The Cas9 protein size allows it to fit effectively within cells facilitating genome editing in areas such as research agriculture and therapeutics. The complexity of CRISPR-Cas9 also includes the interaction with other cellular components that assist in DNA repair post-cleavage.

Pathways

CRISPR-Cas9 plays a role in DNA repair pathways particularly non-homologous end joining and homologous recombination. After Cas9-induced DNA breaks these pathways become active to repair the cleaved DNA. The gene editing process facilitated by CRISPR-Cas9 often involves interaction with DNA repair proteins like ku70/80 and Rad51 in response to induced breaks. This allows for either the incorporation of new genetic material or the modification of existing genes.

CRISPR-Cas9 has potential in treating genetic disorders such as cystic fibrosis and Duchenne muscular dystrophy. By correcting mutated genes scientists aim to restore normal gene function offering potential therapeutic benefits. Additionally CRISPR-Cas9 relates indirectly to p53 a protein known for its tumor suppressor functions because gene-editing processes can sometimes activate p53-dependent pathways leading to cell cycle arrest or apoptosis. This highlights the importance of understanding the broader implications of CRISPR-Cas9 in therapeutic applications.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

CRISPR (clustered regularly interspaced short palindromic repeat) is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids) (PubMed : 21455174). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). In type II CRISPR systems correct processing of pre-crRNA requires a trans-encoded small RNA (tracrRNA), endogenous ribonuclease 3 (rnc) and this protein. The tracrRNA serves as a guide for ribonuclease 3-aided processing of pre-crRNA; Cas9 only stabilizes the pre-crRNA : tracrRNA interaction and has no catalytic function in RNA processing (PubMed : 24270795). Subsequently Cas9/crRNA/tracrRNA endonucleolytically cleaves linear or circular dsDNA target complementary to the spacer; Cas9 is inactive in the absence of the 2 guide RNAs (gRNA). The target strand not complementary to crRNA is first cut endonucleolytically, then trimmed 3'-5' exonucleolytically. DNA-binding requires protein and both gRNAs, as does nuclease activity. Cas9 recognizes the protospacer adjacent motif (PAM) in the CRISPR repeat sequences to help distinguish self versus nonself, as targets within the bacterial CRISPR locus do not have PAMs. DNA strand separation and heteroduplex formation starts at PAM sites; PAM recognition is required for catalytic activity (PubMed : 24476820). Confers immunity against a plasmid with homology to the appropriate CRISPR spacer sequences (CRISPR interference) (PubMed : 21455174).
See full target information cas9

追加のターゲット

CRISPR-Cas9

文献 (25)

Recent publications for all applications. Explore the full list and refine your search

Nucleic acids research 53: PubMed40042815

2025

Deletion of Xist repeat B disrupts cell cycle and asymmetric cell division through Usp9x hyperactivation in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Mingming Liang,Lichao Zhang,Heng Gong,Li Yang,Haijun Wang,Na Song,Liangxue Lai,Wanhua Xie,Zhanjun Li

STAR protocols 5:103418 PubMed39471176

2024

Protocol for high-throughput screening of functional lysine residues in cell fitness.

Applications

Unspecified application

Species

Unspecified reactive species

Ying Bao,Wensheng Wei

The Biochemical journal 481:1143-1171 PubMed39145956

2024

CARD14 signalosome formation is associated with its endosomal relocation and mTORC1-induced keratinocyte proliferation.

Applications

Unspecified application

Species

Unspecified reactive species

Paul A O'Sullivan,Aigerim Aidarova,Inna S Afonina,Joan Manils,Teresa L M Thurston,Rachael Instrell,Michael Howell,Stefan Boeing,Sashini Ranawana,Melanie B Herpels,Riwia Chetian,Matilda Bassa,Helen Flynn,David Frith,Ambrosius P Snijders,Ashleigh Howes,Rudi Beyaert,Anne M Bowcock,Steven C Ley

Nature communications 14:305 PubMed36658146

2023

Development of a versatile nuclease prime editor with upgraded precision.

Applications

WB

Species

Human

Xiangyang Li,Guiquan Zhang,Shisheng Huang,Yao Liu,Jin Tang,Mingtian Zhong,Xin Wang,Wenjun Sun,Yuan Yao,Quanjiang Ji,Xiaolong Wang,Jianghuai Liu,Shiqiang Zhu,Xingxu Huang

Cancer research communications 2:1244-1254 PubMed36969741

2022

Drug-gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition.

Applications

WB

Species

Unspecified reactive species

Kunzah Jamal,Alessandro Galbiati,Joshua Armenia,Giuditta Illuzzi,James Hall,Sabrina Bentouati,Daniel Barrell,Miika Ahdesmäki,Mark J O'Connor,Elisabetta Leo,Josep V Forment

The Journal of neuroscience : the official journal of the Society for Neuroscience : PubMed35667851

2022

Somatic genetics analysis of sleep in adult mice.

Applications

WB

Species

Mouse

Guodong Wang,Qi Li,Junjie Xu,Shuai Zhao,Rui Zhou,Zhenkang Chen,Wentong Jiang,Xue Gao,Shuang Zhou,Zhiyu Chen,Quanzhi Sun,Chengyuan Ma,Lin Chen,Bihan Shi,Ying Guo,Haiyan Wang,Xia Wang,Huaiye Li,Tao Cai,Yibing Wang,Zhineng Chen,Fengchao Wang,Qinghua Liu

Nature communications 13:597 PubMed35105899

2022

Inhibition of base editors with anti-deaminases derived from viruses.

Applications

Unspecified application

Species

Unspecified reactive species

Zhiquan Liu,Siyu Chen,Liangxue Lai,Zhanjun Li

Nature biotechnology 39:1403-1413 PubMed34155407

2021

Genome-wide interrogation of gene functions through base editor screens empowered by barcoded sgRNAs.

Applications

WB

Species

Unspecified reactive species

Ping Xu,Zhiheng Liu,Ying Liu,Huazheng Ma,Yiyuan Xu,Ying Bao,Shiyou Zhu,Zhongzheng Cao,Zeguang Wu,Zhuo Zhou,Wensheng Wei

Development (Cambridge, England) 148: PubMed34143203

2021

A transgenic system for targeted ablation of reproductive and maternal-effect genes.

Applications

WB

Species

Unspecified reactive species

Sylvain Bertho,Odelya Kaufman,KathyAnn Lee,Adrian Santos-Ledo,Daniel Dellal,Florence L Marlow

Stem cells and development 30:714-724 PubMed33938231

2021

Patient-Specific Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells as a Model to Study Autosomal Recessive Hypercholesterolemia.

Applications

Unspecified application

Species

Unspecified reactive species

Parisa Nikasa,Tine Tricot,Nejat Mahdieh,Hossein Baharvand,Mehdi Totonchi,Mohammad Saeid Hejazi,Catherine M Verfaillie
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com